615
Participants
Start Date
June 12, 2014
Primary Completion Date
May 13, 2021
Study Completion Date
May 13, 2021
ABT-450/r/ABT-267
Tablet for oral use
ABT-333
Tablet for oral use
Ribavirin (RBV)
Ribavirin was provided as 200 mg tablets, and dosed based on weight, 1000 to 1200 mg divided twice daily per local label. For example, for participants weighing \< 75 kg, RBV may have been taken orally as 2 tablets in the morning and 3 tablets in the evening which corresponds to a 1000 mg total daily dose. For participants weighing ≥ 75 kg, RBV may have been taken orally as 3 tablets in the morning and 3 tablets in the evening which corresponds to a 1200 mg total daily dose.
The Mount Sinai Hospital /ID# 128682, New York
North Shore University Hospital /ID# 126565, New Hyde Park
Premier Medical Group - GI Division /ID# 127793, Poughkeepsie
Univ Rochester Med Ctr /ID# 127655, Rochester
Medstar Health Research Institute /ID# 128683, Washington D.C.
Digestive Disease Associates - Catonsville /ID# 127624, Catonsville
Johns Hopkins University /ID# 127791, Baltimore
Atrium Health Carolinas Medical Center /ID# 127632, Charlotte
Carolinas Center For Liver Dis /ID# 127788, Statesville
Atlanta Gastro Assoc /ID# 126571, Atlanta
Encore Borland-Groover Clinical Research /Id# 127781, Jacksonville
University of Florida - Archer /ID# 127787, Gainesville
University of Miami /ID# 127622, Miami
South Florida Ctr Gastro, P.A. /ID# 126567, Wellington
Bach and Godofsky Infec Dis /ID# 128685, Bradenton
Gastro One /ID# 127792, Germantown
Duplicate_Indiana University Health /ID# 126573, Indianapolis
Henry Ford Health System /ID# 127783, Detroit
Dean Clinic /ID# 126575, Madison
Minnesota Gastroenterology PA /ID# 126579, Plymouth
St. Louis University /ID# 126564, St Louis
Options Health Research, LLC /ID# 127630, Tulsa
Cure C Consortium /ID# 126570, Houston
TX Liver Inst, Americ Res Corp /ID# 127623, San Antonio
Austin Institute for Clinical Research /ID# 126562, Pflugerville
Univ of Colorado Cancer Center /ID# 126568, Aurora
Clinical Research Ctrs America /ID# 127780, Murray
St. Josephs Hospital and Med Center /ID# 127800, Phoenix
Southwest Care Center /ID# 127784, Santa Fe
Ruane Clinical Research Group /ID# 126577, Los Angeles
Franco Felizarta, Md /Id# 126569, Bakersfield
California Pacific Medical Center /ID# 128681, San Francisco
Virginia Mason - Seattle Orthapedics /ID# 130288, Seattle
University of Washington /ID# 127785, Seattle
Northwestern University Feinberg School of Medicine /ID# 128684, Chicago
The University of Chicago Medical Center /ID# 126576, Chicago
Tulane University /ID# 127779, New Orleans
Louisana Research Center, LLC /ID# 126561, Shreveport
Beth Israel Deaconess Medical Center /ID# 126560, Boston
AGA Clinical Research Associates, LLC /ID# 126578, Egg Harbor
Rutgers New Jersey School of Medicine /ID# 128686, Newark
University of New Mexico /ID# 128859, Albuquerque
Columbia Univ Medical Center /ID# 126566, New York
Columbia Univ Medical Center /ID# 127621, New York
University of Cincinnati Physicians Company, LLC /ID# 127790, Cincinnati
University Gastroenterology /ID# 127789, Providence
Inquest Clinical Research /ID# 126574, Baytown
Liver Associates of Texas, P.A /ID# 126563, Houston
Lead Sponsor
AbbVie
INDUSTRY